These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 11405232

  • 1. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
    Jansen K, Schäfer O, Birkmann E, Post K, Serban H, Prusiner SB, Riesner D.
    Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
    [Abstract] [Full Text] [Related]

  • 2. The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites.
    Leffers KW, Schell J, Jansen K, Lucassen R, Kaimann T, Nagel-Steger L, Tatzelt J, Riesner D.
    J Mol Biol; 2004 Nov 26; 344(3):839-53. PubMed ID: 15533449
    [Abstract] [Full Text] [Related]

  • 3. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H, Stockel J, Mehlhorn I, Groth D, Baldwin MA, Prusiner SB, James TL, Cohen FE.
    Biochemistry; 1997 Mar 25; 36(12):3543-53. PubMed ID: 9132005
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW, Wille H, Stöhr J, Junger E, Prusiner SB, Riesner D.
    Biol Chem; 2005 Jun 25; 386(6):569-80. PubMed ID: 16006244
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ, DeMarco ML, Daggett V.
    Biochemistry; 2004 Oct 19; 43(41):12955-63. PubMed ID: 15476389
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
    Stöhr J, Elfrink K, Weinmann N, Wille H, Willbold D, Birkmann E, Riesner D.
    Biol Chem; 2011 May 19; 392(5):415-21. PubMed ID: 21476870
    [Abstract] [Full Text] [Related]

  • 10. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
    Kuroda Y, Maeda Y, Sawa S, Shibata K, Miyamoto K, Nakagawa T.
    J Pept Sci; 2003 Apr 19; 9(4):212-20. PubMed ID: 12725242
    [Abstract] [Full Text] [Related]

  • 11. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
    Baldwin MA, Pan KM, Nguyen J, Huang Z, Groth D, Serban A, Gasset M, Mehlhorn I, Fletterick RJ, Cohen FE.
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar 29; 343(1306):435-41. PubMed ID: 7913763
    [Abstract] [Full Text] [Related]

  • 12. Spontaneous and BSE-prion-seeded amyloid formation of full length recombinant bovine prion protein.
    Panza G, Stöhr J, Dumpitak C, Papathanassiou D, Weiss J, Riesner D, Willbold D, Birkmann E.
    Biochem Biophys Res Commun; 2008 Sep 05; 373(4):493-7. PubMed ID: 18585368
    [Abstract] [Full Text] [Related]

  • 13. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S, Glockshuber R.
    J Mol Biol; 1996 Sep 06; 261(5):614-9. PubMed ID: 8800210
    [Abstract] [Full Text] [Related]

  • 14. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrP(Sc) accumulation.
    Hafner-Bratkovic I, Gaspersic J, Smid LM, Bresjanac M, Jerala R.
    J Neurochem; 2008 Mar 06; 104(6):1553-64. PubMed ID: 17996023
    [Abstract] [Full Text] [Related]

  • 15. Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction.
    Inouye H, Kirschner DA.
    J Struct Biol; 1998 Mar 06; 122(1-2):247-55. PubMed ID: 9724626
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of oligomeric species in the fibrillization pathway of the yeast prion Ure2p.
    Catharino S, Buchner J, Walter S.
    Biol Chem; 2005 Jul 06; 386(7):633-41. PubMed ID: 16207084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.